-
, biology, and medicine? We’re seeking a talented Scientist to join our dynamic team! Our mission is to develop novel PET imaging agents for widely metastatic cancers and to develop novel radioligand
-
the Department of Chemistry at the University of Iowa is searching for one or two postdoctoral research scientists to investigate two different projects: Project 1: Effect of a Change Agent in Doctoral Education
-
. The initial appointment for this position is for one years, with the potential for extension for a total appointment of up to 4 years based on interest and performance. This position is available immediately
-
the potential for extension for a total appointment of up to 4 years based on interest and performance. This position is available immediately and will begin at a mutually agreed upon date. All qualified
-
on human medicine by studying the impact of novel therapy, screening, or treatment models. Several projects are available and focus on topics such as a pilot project studying lung cancer screening in
-
experiments Design guide RNAs and use CRISPR for gene editing Design AAV vectors for gene therapy on mouse models Capture fluorescent images and quantify data Purify proteins and perform western analyses
-
clinical data, cell culture systems, and mouse models to understand the role of the Hippo pathway and the downstream transcriptional activators TAZ and YAP in sarcomas. Education Requirement: PhD or MD/PhD
-
), and B cell) to pulmonary viral infections and after vaccinations. Applicants should have a strong background in immunology, flow cytometry, as well as experience in rodent models. The selected candidate
-
Department:Pathology Salary Salary:$53,760.00 to Commensurate Position Details Full/Part Time Status:Full Time Percent Time:100% Position Description: By using wild type and genetically modified animal models and
-
-cancer pharmacology Experience working with large datasets Experience with bioinformatic approaches, including the analysis of next-generation sequencing data sets Experience with CRISPR-based approaches